Albumin is a bone protein. Osteoblasts generate albumin first and than collagen. Albumin is a standard constituent of stem cell growth media. We have modified the well-known and safely used human allograft processing protocol by adding a patented serum albumin impregnation step to the procedure. This way the healing power of serum can be harnessed in bone grafting, simply by using BoneAlbuminTM. Since both components, albumin and bone are safely used for decades, there is very little chance of unknown adverse effects. Each of our grafts is processed in licensed bone banks under protocols approved by the competent authorities. Close to 3,000 implantations have been performed since 2011 without any major complication. BoneAlbuminTM is currently marketed as a bone void filler in dentistry and orthopedics, supported by peer-reviewed scientific publications.